Sage Therapeutics Inc (NAS:SAGE)
$ 10.78 0.16 (1.51%) Market Cap: 648.76 Mil Enterprise Value: -64.94 Mil PE Ratio: 0 PB Ratio: 0.92 GF Score: 46/100

SAGE Therapeutics Inc Corporate Call - ECNP Encore Presentation: Zuranolone Data Review Transcript

Oct 04, 2021 / 12:00PM GMT
Release Date Price: $44.35 (-2.08%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot